Clinical Trials Directory

Trials / Completed

CompletedNCT00545753

Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head Lice

A Phase 3 Comparative Safety and Efficacy Study Between NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects >6 Months of Age or Older With Pediculosis Capitis

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
558 (actual)
Sponsor
ParaPRO LLC · Industry
Sex
All
Age
6 Months
Healthy volunteers
Accepted

Summary

A comparative safety and efficacy study of NatrOVA Creme Rinse - 1% versus NIX Creme Rinse, under actual use conditions in subjects 6 months of age or greater who are infested with Pediculosis capitis (human head lice).

Detailed description

This is a Phase 3 multi-site, randomized, evaluator/investigator-blinded, three-arm, parallel group study evaluating the safety and efficacy of NatrOVA Creme Rinse - 1% (with nit combing and without nit combing) versus NIX Creme Rinse in an "actual use" environment.

Conditions

Interventions

TypeNameDescription
DRUGSpinosad10 minute topical application product, following by a complete rinse off.
DRUGSpinosad10 minute topical application followed by a complete rinse off, followed by a nit combing regimen
DRUGPermethrin 1%Topical application for 10 minutes, followed by a complete rinse off, followed by a nit combing regimen

Timeline

Start date
2007-09-01
Primary completion
2008-03-01
Completion
2008-05-01
First posted
2007-10-17
Last updated
2012-10-11
Results posted
2012-10-11

Locations

6 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00545753. Inclusion in this directory is not an endorsement.